Comparison of postremission therapies in adult acute myeloid leukemia: preliminary analysis of an ECOG study. Eastern Cooperative Oncology Group.
Cassileth
P A
PA
University of Pennsylvania Cancer Center, Philadelphia.
Harrington
D P
DP
Hines
J D
JD
Oken
M M
MM
Mazza
J J
JJ
McGlave
P
P
Bennett
J M
JM
Lynch
E
E
O'Connell
M J
MJ
D000293:Adolescent; D000328:Adult; D000368:Aged; D000677:Amsacrine / Q000008:administration & dosage / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D003630:Daunorubicin / Q000008:administration & dosage; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D013866:Thioguanine / Q000008:administration & dosage; D014481:United States / Q000453:epidemiology
D000677:Amsacrine; D003561:Cytarabine; D013866:Thioguanine; D003630:Daunorubicin